New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short

被引:12
|
作者
Dahlback, Bjorn [1 ]
Guo, Li Jun [1 ]
Zoller, Bengt [2 ]
Tran, Sinh [1 ]
机构
[1] Lund Univ, Skane Univ Hosp, Dept Translat Med, Inga Marie Nilssons St 53, S-21428 Malmo, Sweden
[2] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden
基金
瑞典研究理事会;
关键词
deep venous thrombosis; factor V; factor X; protein S; TFPI; TISSUE FACTOR PATHWAY; C4B-BINDING PROTEIN; FACTOR-V; INHIBITOR-ALPHA; COAGULATION; INSIGHTS; DOMAINS; ISOFORMS; BIOLOGY; XA;
D O I
10.1111/jth.14405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Protein S is an anticoagulant cofactor to both activated protein C and tissue factor pathway inhibitor (TFPI alpha). The TFPI alpha-cofactor activity of protein S is stimulated by a short isoform of factor V (FV-Short), the two proteins functioning in synergy. Objective Using the synergistic TFPI alpha-cofactor activity between protein S and FV-Short to develop a functional test for plasma protein S. Patients/Methods TFPI alpha-mediated inhibition of FXa in the presence of FV-Short, protein S and negatively charged phospholipid vesicles was monitored in time by synthetic substrate S2765. TFPI alpha, FXa and FV-Short were purified proteins, whereas diluted plasma from protein S deficient patients or controls were used as source for protein S. Results The assay was specific for free protein S demonstrating good correlation to free protein S plasma levels (r = 0.92) with a Y-axis intercept of -5%. Correlation to concentrations of total protein S (free and C4BP beta+-bound) was lower (r = 0.88) and the Y-axis intercept was +46%, which is consistent with the specificity for free protein S. The test distinguished protein S-deficient individuals from 6 families with known ProS1 mutations from family members having no mutation. Protein S levels of warfarin-treated protein S deficient cases were lower than protein S in cases treated with warfarin for other causes. Conclusions We describe a new assay measuring the TFPI alpha-cofactor activity of plasma protein S. The test identifies type I/III protein S deficiencies and will be a useful tool to detect type II protein S deficiency having defective TFPI alpha-cofactor activity.
引用
收藏
页码:585 / 595
页数:11
相关论文
共 15 条
  • [1] Importance of individual residues in hydrophobic patch PLVIVGL (1481-1487) in FV-Short for synergistic TFPIα cofactor activity with protein S, an alanine-scanning study: AlphaFold-mediated prediction of FV-Short/TFPIα/protein S trimolecular complex structure
    Dahlback, Bjorn
    Tran, Sinh
    Draczkowski, Piotr
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2025, 23 (03) : 849 - 862
  • [2] The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα
    Dahlback, Bjorn
    Tran, Sinh
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (01) : 58 - 68
  • [3] A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S
    Dahlback, Bjorn
    Tran, Sinh
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (05) : 1146 - 1157
  • [4] FV enhances protein S cofactor function for TFPI in the inhibition of FXa
    Reglinska-Matveyev, N.
    Crawley, J. T.
    Camire, R.
    Lane, D. A.
    Ahnstroem, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 54 - 54
  • [5] The TFPIα C-terminal tail is essential for TFPIα-FV-short- protein S complex formation and synergistic enhancement of TFPIα
    Gierula, Magdalena
    Noakes, Victoria M.
    Salles-Crawley, Isabelle I.
    Crawley, James T. B.
    Ahnstrom, Jose fin
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (12) : 3568 - 3580
  • [6] New Functional Assays to Selectively Quantify APC- and TFPI-Cofactor Activities of Protein S in Plasma
    Alshaikh, Nahla
    Rosing, Jan
    Thomassen, Stella
    Castoldi, Elisabetta
    Simioni, Paolo
    Hackeng, Tilman M.
    BLOOD, 2016, 128 (22)
  • [7] Protein S K196E mutation reduces its cofactor activity for APC but not for TFPI
    Maruyama, Keiko
    Akiyama, Masashi
    Miyata, Toshiyuki
    Kokame, Koichi
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (04) : 751 - 756
  • [8] Factor V Atlanta: A Novel Mutation in the F5 Gene Reveals Potential New Cis-Acting Elements Involved in Regulating FV-Short and TFPI Levels
    Zimowski, Karen L.
    Ho, Michelle D.
    Shields, Jordan E.
    Denning, Gabriela
    Petrillo, Teodolinda
    Jhita, Navdeep
    Rivera, Angel A.
    Escobar, Miguel A.
    Kempton, Christine L.
    Doering, Christopher B.
    Camire, Rodney M.
    BLOOD, 2017, 130
  • [9] A FUNCTIONAL TEST FOR PROTEIN-S ACTIVITY IN PLASMA
    VANDEWAART, P
    PREISSNER, KT
    BECHTOLD, JR
    MULLERBERGHAUS, G
    THROMBOSIS RESEARCH, 1987, 48 (04) : 427 - 437
  • [10] Citrullination of TFPI By PAD4 Impairs Its Natural Anticoagulant Activity Towards Factors Xa, VIIa and Tissue Factor, and Reduces Binding to Its Cofactor Protein S
    Bouwens, Bryan
    Magdeleyns, Elke
    Thomassen, Stella
    Suylen, Dennis
    Hackeng, Tilman M.
    Koenen, Rory R.
    BLOOD, 2024, 144 : 3994 - 3994